Hypomethylation of the 14-3-3σ promoter leads to increased expression in non-small cell lung cancer

Genes Chromosomes and Cancer

Volumn 50, Issue 10, 2011, Pages 830-836

  Radhakrishnan, Vijayababu M ^a,b   Jensen, Taylor J ^a,c   Cui, Haiyan ^a   Futscher, Bernard W ^a,b   Martinez, Jesse D ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c SEQUENOM INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; STRATIFIN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DNA METHYLATION; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

14-3-3 PROTEINS; CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXONUCLEASES; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 80051572927     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20904     Document Type: Article

References (32)

1. Akahira J, Sugihashi Y, Suzuki T, Ito K, Niikura H, Moriya T, Nitta M, Okamura H, Inoue S, Sasano H, Okamura K, Yaegashi N. 2004. Decreased expression of 14-3-3σ is associated with advanced disease in human epithelial ovarian cancer: Its correlation with aberrant DNA methylation. Clin Cancer Res 10: 2687-2693.
2. Albertson DG. 2006. Gene amplification in cancer. Trends Genet 22: 447-455.
3. Bhatia K, Siraj AK, Hussain A, Bu R, Gutierrez MI. 2003. The tumor suppressor gene 14-3-3σ is commonly methylated in normal and malignant lymphoid cells. Cancer Epidemiol Biomarkers Prev 12: 165-169.
4. Cho M, Uemura H, Kim SC, Kawada Y, Yoshida K, Hirao Y, Konishi N, Saga S, Yoshikawa K. 2001. Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma. Br J Cancer 85: 563-567.
5. Coolen MW, Statham AL, Gardiner-Garden M, Clark SJ. 2007. Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: Critical evaluation and improvements. Nucleic Acids Res 35: e119.
6. Feinberg AP, Vogelstein B. 1983. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-92.
7. Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, Marks JR, Lambers AR, Futreal PA, Stampfer MR, Sukumar S. 2000. High frequency of hypermethylation at the 14-3-3σ locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 97: 6049-6054.
8. Gasco M, Sullivan A, Repellin C, Brooks L, Farrell PJ, Tidy JA, Dunne B, Gusterson B, Evans DJ, Crook T. 2002. Coincident inactivation of 14-3-3σ and p16INK4a is an early event in vulval squamous neoplasia. Oncogene 21: 1876-1881.
9. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B. 1997. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol Cell 1: 3-11.
10. Ito Y, Miyoshi E, Uda E, Yoshida H, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Matsuura N, Kakudo K, Kuma K, Miyauchi A. 2003. 14-3-3σ possibly plays a constitutive role in papillary carcinoma, but not in follicular tumor of the thyroid. Cancer Lett 200: 161-166.
11. Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K. 2000. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3σ gene in human hepatocellular carcinoma. Oncogene 19: 5298-5302.
12. Kaneuchi M, Sasaki M, Tanaka Y, Shiina H, Verma M, Ebina Y, Nomura E, Yamamoto R, Sakuragi N, Dahiya R. 2004. Expression and methylation status of 14-3-3σ gene can characterize the different histological features of ovarian cancer. Biochem Biophys Res Commun 316: 1156-1162.
13. Kuramitsu Y, Baron B, Yoshino S, Zhang X, Tanaka T, Yashiro M, Hirakawa K, Oka M, Nakamura K. 2010. Proteomic differential display analysis shows up-regulation of 14-3-3σ protein in human scirrhous-type gastric carcinoma cells. Anticancer Res 30: 4459-4465.
14. Leffers H, Madsen P, Rasmussen HH, Honore B, Andersen AH, Walbum E, Vandekerckhove J, Celis JE. 1993. Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway. J Mol Biol 231: 982-998.
15. Lodygin D, Diebold J, Hermeking H. 2004. Prostate cancer is characterized by epigenetic silencing of 14-3-3σ expression. Oncogene 23: 9034-9041.
16. Massion PP, Kuo WL, Stokoe D, Olshen AB, Treseler PA, Chin K, Chen C, Polikoff D, Jain AN, Pinkel D, Albertson DG, Jablons DM, Gray JW. 2002. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: Implications of the phosphatidylinositol 3-kinase pathway. Cancer Res 62: 3636-3640.
17. Mhawech P. 2005. 14-3-3 proteins-An update. Cell Res 15: 228-236.
18. Moreira JM, Gromov P, Celis JE. 2004. Expression of the tumor suppressor protein 14-3-3σ is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition. Mol Cell Proteomics 3: 410-419.
19. Moreira JM, Ohlsson G, Rank FE, Celis JE. 2005. Down-regulation of the tumor suppressor protein 14-3-3σ is a sporadic event in cancer of the breast. Mol Cell Proteomics 4: 555-569.
20. Morrison DK. 2009. The 14-3-3 proteins: Integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 19: 16-23.
21. Muhlmann G, Ofner D, Zitt M, Muller HM, Maier H, Moser P, Schmid KW, Amberger A. 2010. 14-3-3σ and p53 expression in gastric cancer and its clinical applications. Dis Markers 29: 21-29.
22. Nakayama M, Wada M, Harada T, Nagayama J, Kusaba H, Ohshima K, Kozuru M, Komatsu H, Ueda R, Kuwano M. 1998. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. Blood 92: 4296-4307.
23. Okada T, Masuda N, Fukai Y, Shimura T, Nishida Y, Hosouchi Y, Kashiwabara K, Nakajima T, Kuwano H. 2006. Immunohistochemical expression of 14-3-3σ protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas. Anticancer Res 26: 3105-3110.
24. Qi W, Liu X, Qiao D, Martinez JD. 2005. Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer 113: 359-363.
25. Radhakrishnan VM, Martinez JD. 2010. 14-3-3γ induces oncogenic transformation by stimulating MAP kinase and PI3K signaling. PLoS One 5: e11433.
26. Rodriguez JA, Li M, Yao Q, Chen C, Fisher WE. 2005. Gene overexpression in pancreatic adenocarcinoma: Diagnostic and therapeutic implications. World J Surg 29: 297-305.
27. Rosty C, Ueki T, Argani P, Jansen M, Yeo CJ, Cameron JL, Hruban RH, Goggins M. 2002. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol 160: 45-50.
28. Sano T, Shimooka H, Weixa P, Segawa A, Jian Z, Motegi A, Nakayama H, Oyama T, Nakajima T. 2004. Immunohistochemical expression of 14-3-3σ protein in various histological subtypes of uterine cervical cancers. Pathol Int 54: 743-750.
29. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Imai K. 2000. Inactivation of the 14-3-3σ gene is associated with 5' CpG island hypermethylation in human cancers. Cancer Res 60: 4353-4357.
30. Tanaka K, Hatada T, Kobayashi M, Mohri Y, Tonouchi H, Miki C, Nobori T, Kusunoki M. 2004. The clinical implication of 14-3-3σ expression in primary gastrointestinal malignancy. Int J Oncol 25: 1591-1597.
31. Uchida D, Begum NM, Almofti A, Kawamata H, Yoshida H, Sato M. 2004. Frequent downregulation of 14-3-3σ protein and hypermethylation of 14-3-3σ gene in salivary gland adenoid cystic carcinoma. Br J Cancer 91: 1131-1138.
32. Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S. 2001. Hypermethylation of 14-3-3σ (stratifin) is an early event in breast cancer. Oncogene 20: 3348-3353.